Correlation between c-erbB-4 receptor expression and response to gemcitabine–cisplatin chemotherapy in non-small-cell lung cancer
Authors:
- O. MerimskyOMO. Merimsky
- M. InbarMIM. Inbar
- N. WiglerNWN. Wigler
Open Access
- 1 August 2001
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 12 (8) , 1127-1131
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prognostic significance of BAG-1 expression in non-small cell lung cancerLung Cancer, 2000
- Epidermal growth factor receptor in stage I non-small cell lung cancer — The relationship between concentration and prognosisLung Cancer, 2000
- HLA frequency and prognosis in non-small cell lung carcinomaLung Cancer, 2000
- Gemcitabine and Cisplatin as Induction Regimen for Patients With Biopsy-Proven Stage IIIA N2 Non–Small-Cell Lung Cancer: A Phase II Study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)Journal of Clinical Oncology, 2000
- Molecular biologic substaging of stage I lung cancer according to gender and histologyThe Annals of Thoracic Surgery, 2000
- Monthly gemcitabine (days 1, 8 and 15) plus cisplatin (days 1-3) in advanced non-small cell lung cancer: a phase II studyAnti-Cancer Drugs, 2000
- A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markersThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein.Journal of Clinical Oncology, 1997
- Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung.Journal of Clinical Oncology, 1995
- Epidermal growth factor receptors in non-small cell lung cancerBritish Journal of Cancer, 1987